Cargando…

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma

BACKGROUND: Interleukin 6 (IL6) is both a pleiotropic cytokine and an immune-related gene. Interleukin 6 receptor (IL6R) is the receptor for IL6. It may be closely connected to the development of lung cancer. This research aims to explore the prognostic value of IL6R and prevent overtreatment of pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Gaofeng, Wang, Tianyi, Shi, Muqi, Zhou, Hao, Wang, Jinjie, Huang, Zhanghao, Zhang, Haijian, Shi, Jiahai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339841/ https://www.ncbi.nlm.nih.gov/pubmed/34422969 http://dx.doi.org/10.21037/atm-21-36

Ejemplares similares

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration
por: Wang, Jinjie, et al.
Publicado: (2022)

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment
por: Zhou, Hao, et al.
Publicado: (2021)

Prognostic signature of lung adenocarcinoma based on stem cell-related genes
por: Huang, Zhanghao, et al.
Publicado: (2021)

Identification of lysosomal genes associated with prognosis in lung adenocarcinoma
por: Li, Houqiang, et al.
Publicado: (2023)

GPR115 Contributes to Lung Adenocarcinoma Metastasis Associated With LAMC2 and Predicts a Poor Prognosis
por: Wang, Yingjing, et al.
Publicado: (2020)

High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma
por: Xu, Zhangyan, et al.
Publicado: (2020)

Identification of a polycomb group-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2023)

Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma
por: Chen, Yuhua, et al.
Publicado: (2021)

A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma
por: Li, Qixuan, et al.
Publicado: (2023)

Extrachromosomal circular DNA: a new potential role in cancer progression
por: Wang, Tianyi, et al.
Publicado: (2021)

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma
por: Zhang, Peng, et al.
Publicado: (2022)

Exploration of the shared genes and signaling pathways between lung adenocarcinoma and idiopathic pulmonary fibrosis
por: Li, Houqiang, et al.
Publicado: (2023)

GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma
por: Peng, Yunsong, et al.
Publicado: (2022)

Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer
por: Zhu, Jiaqi, et al.
Publicado: (2022)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma
por: Zhang, Lina, et al.
Publicado: (2013)

ADCY9 functions as a novel cancer suppressor gene in lung adenocarcinoma
por: Tang, Yijie, et al.
Publicado: (2023)

Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia–Reperfusion Injury
por: Zhou, Tingting, et al.
Publicado: (2022)

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma
por: Zhou, Xincheng, et al.
Publicado: (2022)

Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma
por: Yang, Min, et al.
Publicado: (2018)

Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients
por: Wang, Wenmiao, et al.
Publicado: (2022)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway
por: Wang, Shuo, et al.
Publicado: (2023)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
por: Fan, Yongfei, et al.
Publicado: (2022)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
por: Zhang, Shusen, et al.
Publicado: (2020)

SMOX expression predicts the prognosis of non-small cell lung cancer
por: Huang, Zhanghao, et al.
Publicado: (2021)

Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma
por: Huang, Xiaoyue, et al.
Publicado: (2022)

High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma
por: Han, Rui, et al.
Publicado: (2023)

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

CT Radiomics Combined With Clinicopathological Features to Predict Invasive Mucinous Adenocarcinoma in Patients With Lung Adenocarcinoma
por: Zhang, Junjie, et al.
Publicado: (2023)

Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
por: Yun, Sumi, et al.
Publicado: (2016)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

High Expression of DEPDC1B Predicts Poor Prognosis in Lung Adenocarcinoma
por: Li, Pulin, et al.
Publicado: (2022)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_06intap94s91kum9eis8pfquo6